Consort Partners’ Post

IgniteData has successfully closed its fully subscribed $8 million seed round. This round was led by SpringTide Ventures, who has joined the IgniteData board alongside existing strategic investor, ZS. SpringTide’s co-investors are Oncology Ventures and Frank Naeymi-Rad, co-founder of Intelligent Medical Objects, Inc. and a Chairman of Leap of Faith Technologies, Inc. In addition to the new coalition of investors, IgniteData received further backing from Innovate UK in the form of an additional grant and R&D loan. The funding will enhance IgniteData’s ability to scale at an accelerated pace to meet growing demand from leading research sites and sponsors, while expanding the company’s product suite. $8 million seed investment round turbocharges IgniteData’s growth - read full news release here: https://lnkd.in/eJgvarR2 Ryan Morley Ben Freeberg Frank Naeymi-Rad Zach Taft, MBA #innovation #growth #healthtech #interoperability #clinicaltrials

Recent developments in health are pretty exciting, focusing on bridging the gap between treatment and prevention and leveraging AI for automation and early disease detection. For instance, Octopus Investments Ventures highlighted the consumerisation of healthcare and AI-led automation as critical trends. Additionally, Israeli venture capital firm Pitango raised $175 million for a healthcare fund, investing in startups like Nevia Bio for women's health and QuantHealth for AI-led clinical trial simulations. #Healthtech

SoundHealth Secures $7 Million Seed Funding to Improve Respiratory Health A California-based medical technology startup, SoundHealth Inc., has secured $7 million in seed funding to support the commercialization and marketing of SONU, an innovative wearable medical device designed to treat moderate to severe nasal congestion caused by an allergic reaction or non-allergic rhinitis. Recently launched by SoundHealth, SONU is the world’s first AI-enabled medical device of its kind to receive De Novo approval from the US Food and Drug Administration(FDA). According to SoundHealth’s announcement, the seed round was co-led by Moai Capital and J4.Ventures, with the support of other investors, including TeleSoft Partners, TechU Ventures, Tau Ventures, and Rhythm Venture Capital. Read more: https://lnkd.in/g8SPwNG7 #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

From powering connectivity at Coachella (Transcelestial) to being accepted into competitive accelerator programs in the US run by top hospital systems in Cedars-Sinai and Mayo Clinic (Kinexcs, Vivance, Respiree), our portfolio companies have been keeping busy this past quarter and we are excited by the progress they have made. Buckle up as we prepare for a busy fourth quarter ahead and end off 2024 on a good note. Meanwhile, scroll to see updates of recent investments we’ve made into BluMaiden Biosciences, CoNEX Healthcare, Vertical Oceans, and follow-on capital into DiMuto, The Gentle Group, Meridian Innovation, and Willowmore. Join us in celebrating the successes of our startups Aliena Pte Ltd, Auristone Pte Ltd, Botsync, igloo, Insectta, Kinexcs, Mesh Bio, Neuron Mobility, Singrow Pte Ltd, Transcelestial, Qritive as well as our partners Coronet Ventures (Cedars-Sinai) and AgFunder. Follow SEEDS Capital and stay tuned for more insights on the venture capital landscape.⬇️ 👉 #deeptech #innovation #venturecapital #singapore #investmentrecap 

Such great news for the biotech and life sciences start-up space in Europe! From Goldman Sachs' first Life Sciences VC Fund to Earlybird's Health Tech fund, these achievements demonstrate the industry's recognition of the importance of private companies in the health tech sector, which can help address the shortcomings of the public healthcare system and drive innovation. I am more than thrilled to witness the potential impact these start-ups can have in revolutionizing the healthcare industry! E11evate #venturecapital #venturestudio #healthtech #biotech #medtech

🙌 This week saw some large funding rounds by female founders and their teams. Healthtech and Biotech are still taking the top spot for the most number of raises, so let's jump into this week's #HypeCorner 👇 🇸🇪 Susanna Campbell Co-founder & Chairman of Syre  🇫🇷 Margot Karlikow, PhD - Co-founder & CTO of En Carta Diagnostics 🇳🇱 Marieke Jongma Co-founder & COO of VRelax 🇪🇪 Anna Strubel & Carina Vantsi Co-founders of CARÁ Health 🇩🇰 Isabel Álvarez-Martos Co-founder & CEO of CELLUGY® 🇨🇭 Daniela Marino & Fabienne Hartmann-Fritsch Co-founders of CUTISS AG 🇫🇮 Karita Kinnunen-Raudaskoski Co-founder & CTO of Fiberwood Ltd 🇬🇧 Aleksandra Mitrevska Co-founder & COO of Native Teams  🇫🇷 Martine Caroff Founder, Investor & CSO of HEPHAISTOS-Pharma I am excited to see what the next phase of growth looks like for these founders and their teams. Congrats again to all on the above funding rounds! 👏 HAVE A GREAT WEEKEND! ☀ ___________________________________________________________________ Each week I publish the #Unstoppable Female Founders newsletter including a list of funding rounds by female founders titled the #HypeCorner. Subscribe to get my weekend newsletter. Link in comments! #femalefounders #funding #VC #investment #founder #startup #biotech #climatetech #saas #femtech

#fundingalert 💼Company: Vivalyx  💰Funding: €5.4Million ⚡Round: Seed 👥Investors: Consortium, Brightlands Venture Partners, TVF | TechVision Fonds, Arve Capital, Thomas Ebeling, Andrej Henkler, Springboard Health Angels. Vivalyx GmbH, a biotech company was founded in 2022 in Aachen by Andreas Schumacher, Benedict Doorschodt, René H. Tolba, Christian Bleilevens, Malte Brettel, and Marius Rosenberg. The funding enables it to finance the clinical study required for regulatory approval. This crucial step paves the way for the launch of the innovative organ preservation solution, which has the potential to extend the lifespan of donor organs and enhance their vitality. Luc Starmans, Bernhard Kugel, Andrej Henkler Read more - https://lnkd.in/ggpZz5wE To share your startup story write us on - contact@startuprise.co.uk #Vivalyx #biotech #finance #vitality #funding #fundingnews #startupnews #startuprise

THE ABRAHAMIC BUSINESS CIRCLE family is excited to warmly welcome Gilad, adding his expertise and enthusiasm to our vibrant community of forward-thinkers and trailblazers. Gilad Peleg, a founding partner at Neuro1 Capital, a pioneering investment vehicle, in cutting-edge neurotech ventures and proprietary neurotech IP.  Neuro1 Capital's mission is to accelerate the development and commercialization of superior medical neurotech solutions, as well as leveraging data for prediction, prevention, and personalization of medical interventions. Gilad is a seasoned health-tech executive and investor with over 30 years of diverse experience, spanning corporate pharma, med-tech startups, and venture capital. Also, serving as Co-Founder and General Managing Partner at Corundum Open Innovation, he drove investments in med-tech ventures. Additionally, as Co-Founder of Joy Ventures, Gilad advanced neuro-wellness technologies globally. Throughout his illustrious career, Gilad held pivotal roles such as Chief Operating Officer at Rainbow Medical, CEO at NanoCyte Inc., and Business Development Director at Teva Pharmaceuticals (NASDAQ: TEVA), orchestrating successful investment and exit transactions.  Today, Gilad continues to strive to shape the future of health-tech through innovative investment initiatives. Once again, congratulations, and let's work together towards prosperity! Dr. Raphael Nagel (LL.M.) Be a part of our business community. Register now! Phone #: +971544451408 / +971508653204 Email add: contact@theabrahamicbusinesscircle.com #TheAbrahamicBusinessCircle #InvestorsRoundtable #ViennaBusiness #BusinessNetworking #InvestmentOpportunity #GlobalBusiness #BusinessLeaders #NetworkingEvent #Entrepreneurship #IndustryInsights #EconomicDevelopment #BusinessGrowth #StrategicPartnerships #LeadershipForum #InnovationHub #FutureofBusiness #Collaboration #GlobalCommunity #EconomicDiplomacy #GlobalAlliances

📣 Investor Insights - Shaping Success for Early-Stage Ventures Join our panel of #MedtechLeaders as they discuss: · What strategies can early-stage medtech companies adopt to align with investor expectations for risk reduction and innovation · What are some successful strategies that early-stage medtech companies have employed to bridge the gap between initial funding and market viability · What specific attributes do you look for in medtech companies to determine their potential for reduced risk, scalability, and innovation 🎙 Hear from: ·  Jennifer McMahon, Partner, Seroba. Life Sciences ·  Diana Saraceni, General Partner, Panakes Partners ·  Klaus Stöckemann, Managing Director & Co-Founder, Peppermint Venture Partners GmbH Find out more: https://lnkd.in/efnAaEYC #LSXWorld 

Amplitude Ventures Closes $263M for Second Precision Medicine Fund https://lnkd.in/gZ2g3xj7 Amplitude Ventures has successfully closed a $263 million funding round for its second precision medicine fund. This fund will be used to support innovative ventures in the field of precision medicine. #precisionmedicine #healthcare #innovation The Leaders Magazine